Literature DB >> 32953620

The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer.

Nikolaos Kalampokis1, Nikolaos Grivas1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32953620      PMCID： PMC7475370          DOI： 10.21037/gs.2020.02.12

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  12 in total

Review 1.  Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.

Authors:  Guillaume Ploussard; Giorgio Gandaglia; Hendrik Borgmann; Pieter de Visschere; Isabel Heidegger; Alexander Kretschmer; Romain Mathieu; Cristian Surcel; Derya Tilki; Igor Tsaur; Massimo Valerio; Roderick van den Bergh; Piet Ost; Alberto Briganti
Journal:  Eur Urol       Date:  2018-10-31       Impact factor: 20.096

2.  Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.

Authors:  R Jeffrey Karnes; Christopher R Murphy; Eric J Bergstralh; Guy DiMonte; John C Cheville; Val J Lowe; Lance A Mynderse; Eugene D Kwon
Journal:  J Urol       Date:  2014-08-20       Impact factor: 7.450

3.  25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.

Authors:  Christopher R Porter; Koichi Kodama; Robert P Gibbons; Roy Correa; Felix K-H Chun; Paul Perrotte; Pierre I Karakiewicz
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

4.  Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.

Authors:  Florentien J Hinsenveld; Esther M K Wit; Pim J van Leeuwen; Oscar R Brouwer; Maarten L Donswijk; Corinne N Tillier; Erik Vegt; Erik van Muilekom; Matthias N van Oosterom; Fijs W B van Leeuwen; Henk G van der Poel
Journal:  J Nucl Med       Date:  2019-09-27       Impact factor: 10.057

5.  Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy.

Authors:  Derya Tilki; Philipp Mandel; Flora Seeliger; Alexander Kretschmer; Alexander Karl; Süleyman Ergün; Michael Seitz; Christian G Stief
Journal:  J Urol       Date:  2014-08-30       Impact factor: 7.450

Review 6.  Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.

Authors:  Guillaume Ploussard; Christophe Almeras; Alberto Briganti; Gianluca Giannarini; Christophe Hennequin; Piet Ost; Raphaële Renard-Penna; Ambroise Salin; Thierry Lebret; Arnauld Villers; Michel Soulié; Alexandre de la Taille; Vincent Flamand
Journal:  J Urol       Date:  2015-05-09       Impact factor: 7.450

7.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.

Authors:  Philip Cornford; Joaquim Bellmunt; Michel Bolla; Erik Briers; Maria De Santis; Tobias Gross; Ann M Henry; Steven Joniau; Thomas B Lam; Malcolm D Mason; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Thomas Wiegel; Nicolas Mottet
Journal:  Eur Urol       Date:  2016-08-31       Impact factor: 20.096

8.  (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

Authors:  Pim J van Leeuwen; Phillip Stricker; George Hruby; Andrew Kneebone; Francis Ting; Ben Thompson; Quoc Nguyen; Bao Ho; Louise Emmett
Journal:  BJU Int       Date:  2016-01-24       Impact factor: 5.588

9.  Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.

Authors:  Matthias Eiber; Tobias Maurer; Michael Souvatzoglou; Ambros J Beer; Alexander Ruffani; Bernhard Haller; Frank-Philipp Graner; Hubert Kübler; Uwe Haberkorn; Michael Eisenhut; Hans-Jürgen Wester; Jürgen E Gschwend; Markus Schwaiger
Journal:  J Nucl Med       Date:  2015-03-19       Impact factor: 10.057

10.  Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.

Authors:  Nicola Fossati; Nazareno Suardi; Giorgio Gandaglia; Carlo A Bravi; Matteo Soligo; R Jeffrey Karnes; Shahrokh Shariat; Antonino Battaglia; Wouter Everaerts; Steven Joniau; Hendrik Van Poppel; Nieroshan Rajarubendra; Inderbir S Gill; Alessandro Larcher; Alexander Mottrie; Maximilian Schmautz; Axel Heidenreich; Almut Kalz; Daniar Osmonov; Klaus-Peter Juenemann; Annika Herlemann; Christian Gratzke; Christian Stief; Francesco Montorsi; Alberto Briganti
Journal:  Eur Urol       Date:  2018-10-06       Impact factor: 24.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.